Many people with advanced Parkinson's disease are currently required to take more than 20 pills a day to manage their symptoms, while some necessitate
treatment through a permanent feeding tube.
Soon, patients will only be required to wear a portable kit to get a continuous dose of the medication delivered into their bloodstream 24 hours a day.
This innovative treatment, called Produodopa, will now be made available on the NHS, providing benefit to nearly 1,000 people with advanced Parkinson's disease,
according to a BBC report.
James Palmer, NHS England's medical director for specialised services, told the publication that the drug's rollout will offer "a vital new option on the NHS for
those who aren't suitable for other treatments such as deep brain stimulation."
He added that the new therapy will help patients manage their symptoms "more effectively" and improve their quality of life.
Opella Healthcare, trading as Sanofi Consumer Healthcare, said it has entered into a dual partnership agreement with Alliance Healthcare and Phoenix
Healthcare Distribution for the wholesale supply of its products to UK pharmacies.
In effect from the start of February, the new dual partnership will ensure Sanofi Consumer Healthcare 'continues to provide its customers with exceptional
customer service', the company said, adding that the increased efficiency will facilitate improved service levels and stock availability of Cialis Together,
Allevia, Buscopan, Dulcolax and Phenergan to community pharmacies in the UK.
"At Sanofi Consumer Healthcare we are committed to supporting the self-care agenda in the UK," Nick Linton, head of UK country operations, commented.
"Making healthcare as simple as it should be to bring health and wellbeing to all is a key priority for us in 2024 and beyond. Our new wholesale model reflects our
deep commitment to working as efficiently as possible in close partnership with pharmacists to shape a healthier future."
Community Pharmacy England (CPE), the Company Chemists' Association (CCA), the Royal Pharmaceutical Society (RPS) and the National Pharmacy Association
(NPA) on Tuesday (5 March) released a joint manifesto for community pharmacy in anticipation of the upcoming general election expected later this year.
The manifesto has been designed for widespread use within the community pharmacy sector to facilitate engagement with political parties and parliamentary candidates.
In their #VotePharmacy manifesto, the pharmacy bodies have highlighted a robust six-point plan to unleash the potential of pharmacy.
Election candidates are urged to express their support in six key areas, which include:
Filling the funding gap and committing to long-term sustainable funding to empower pharmacies to deliver more NHS care.
Enhancing the community pharmacy workforce to ensure they can meet the evolving needs of patients.
LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the
company's new Chief Executive Officer (CEO).
Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.
With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies.
He has also co-authored "The Little Black Book of Change."
Adams will lead the LPCH's mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within
homecare and community settings while improving accessibility.
A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic
productivity.
The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick
leave.
According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight.
The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and
heart disease.
In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.
